Máster en Alimentación, Ética y Derecho

Cátedra UNESCO de Bioética

Contacto

 

"Abuses of FDA Regulatory Procedures — The Case of Suboxone"

The New England Journal of Medicine

The manufacturer of brand-name buprenorphine products exploited various FDA regulatory procedures to impede market entry of generic competitors and to maintain high prices. This case provides an example of the kinds of abuses that are common in prescription-drug markets.